ArticleVaccine: X2020

Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting.

Timothy Kinyanjui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.